Drug Development Solutions 

Drug Development Solutions (DDS)

The team at DDS, Cambridge (Fordham), UK have created optimization and validation protocols to ensure the rapid development of bioanalytical methods for the measurement of pharmaceuticals, biopharmaceuticals and biomarkers using microsampling devices.

DDS supports pharmaceutical industry partners in providing analytical solutions within regulatory studies, in turn opening the potential for greater use of patient-centric sampling strategies and the associated benefits, including cost reduction, simpler logistics and greater patient accessibility.

DDS is well positioned to offer advice on benefits and drawbacks of different microsampling devices and the associated strategies that underly the delivery of a fit-for-purpose methodology, whether using mass spectrometry or immunochemistry. We can offer regulatory studies employing microsampling devices within method development, validation and sample analysis and our team is dedicated to providing high quality data, enabling critical drug development decisions.